Literature DB >> 12681370

Blockade of the locomotor stimulant effects of amphetamine by group I, group II, and group III metabotropic glutamate receptor ligands in the rat nucleus accumbens: possible interactions with dopamine receptors.

H N David1, J H Abraini.   

Abstract

Previous investigations have shown that mGlu receptors would be involved in the amphetamine-induced motor response. However, data are somewhat controversial across studies where methodological protocols vary. The aim of the present study was to determine the involvement of mGlu receptors in the NAcc in the locomotor-activating properties of amphetamine in rats well habituated to their experimental environment, a condition known to modulate the motor response to amphetamine. Focal infusion of the group I mGlu receptor antagonist S-4-CPG, which has no effect on basal motor activity, virtually suppressed the locomotor response to amphetamine, while infusion of the group II mGlu receptor antagonist LY 341495 or the group III mGlu receptor agonist AP4, at the minimal dose that produces locomotor activation, reduced it by approximately a half. These effects were blocked by the group I mGlu receptor agonist DHPG, the group II mGlu receptor agonist APDC, and the group III mGlu receptor antagonist MPPG, respectively. These data confirm that mGlu receptors in the NAcc contribute to the psychostimulant motor effect of amphetamine. Results are discussed from the view of recent neuropharmacological studies that have defined the effects of these mGlu receptor ligands on basal motor activity and DA receptor agonists-induced locomotor responses in rats exposed to similar experimental procedures (Eur J Neuroscience 13 (2001) 2157; Neuropharmacology 41 (2001) 454; Eur J Neuroscience 13 (2001) 869). It is suggested that the contribution of mGlu receptors to the amphetamine-induced motor response may result mainly from their functional, either direct or indirect, interactions with D1-like receptors in the NAcc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12681370     DOI: 10.1016/s0028-3908(03)00052-2

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  12 in total

1.  Effects of group I metabotropic glutamate receptor antagonists on the behavioral sensitization to motor effects of cocaine in rats.

Authors:  Olga A Dravolina; Wojciech Danysz; Anton Y Bespalov
Journal:  Psychopharmacology (Berl)       Date:  2006-06-20       Impact factor: 4.530

Review 2.  Group III metabotropic glutamate receptors: pharmacology, physiology and therapeutic potential.

Authors:  Marion S Mercier; David Lodge
Journal:  Neurochem Res       Date:  2014-08-22       Impact factor: 3.996

3.  Behavioral phenotyping and dopamine dynamics in mice with conditional deletion of the glutamate transporter GLT-1 in neurons: resistance to the acute locomotor effects of amphetamine.

Authors:  Kathryn D Fischer; Alex C W Houston; Rajeev I Desai; Michelle R Doyle; Jack Bergman; Maha Mian; Rebekah Mannix; David L Sulzer; Se Joon Choi; Eugene V Mosharov; Nathaniel W Hodgson; Anita Bechtholt; Klaus A Miczek; Paul A Rosenberg
Journal:  Psychopharmacology (Berl)       Date:  2018-02-22       Impact factor: 4.530

Review 4.  Group III metabotropic glutamate receptors and drug addiction.

Authors:  Limin Mao; Minglei Guo; Daozhong Jin; Bing Xue; John Q Wang
Journal:  Front Med       Date:  2013-12       Impact factor: 4.592

Review 5.  Metabotropic glutamate 7 (mGlu7) receptor: a target for medication development for the treatment of cocaine dependence.

Authors:  Xia Li; Zheng-Xiong Xi; Athina Markou
Journal:  Neuropharmacology       Date:  2012-04-21       Impact factor: 5.250

Review 6.  Calcium-dependent networks in dopamine-glutamate interaction: the role of postsynaptic scaffolding proteins.

Authors:  Andrea de Bartolomeis; Carmine Tomasetti
Journal:  Mol Neurobiol       Date:  2012-07-05       Impact factor: 5.590

7.  Enhanced sensitivity to group II mGlu receptor activation at corticostriatal synapses in mice lacking the familial parkinsonism-linked genes PINK1 or Parkin.

Authors:  G Martella; P Platania; D Vita; G Sciamanna; D Cuomo; A Tassone; A Tscherter; T Kitada; P Bonsi; J Shen; A Pisani
Journal:  Exp Neurol       Date:  2008-11-21       Impact factor: 5.330

8.  Enhanced cocaine responsiveness and impaired motor coordination in metabotropic glutamate receptor subtype 2 knockout mice.

Authors:  Yosuke Morishima; Tsuyoshi Miyakawa; Tomoyuki Furuyashiki; Yasuhiro Tanaka; Hiroshi Mizuma; Shigetada Nakanishi
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-07       Impact factor: 11.205

9.  Effect of the mGluR5 antagonist 6-methyl-2-(phenylethynyl)pyridine (MPEP) on the acute locomotor stimulant properties of cocaine, D-amphetamine, and the dopamine reuptake inhibitor GBR12909 in mice.

Authors:  Andrew J Mcgeehan; Patricia H Janak; M Foster Olive
Journal:  Psychopharmacology (Berl)       Date:  2004-07       Impact factor: 4.530

10.  Interactions between the mGluR2/3 agonist, LY379268, and cocaine on in vivo neurochemistry and behavior in squirrel monkeys.

Authors:  Rayna M Bauzo; Heather L Kimmel; Leonard L Howell
Journal:  Pharmacol Biochem Behav       Date:  2009-08-22       Impact factor: 3.533

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.